Immuneering Corp Stock Analysis

Immuneering Stock Analysis Notes

About 24.0% of the company shares are held by company insiders. The book value of Immuneering Corp was currently reported as 1.16. The company recorded a loss per share of 1.97. Immuneering Corp had not issued any dividends in recent years. Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited. Immuneering Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people. To learn more about Immuneering Corp call the company at 617 500 8080 or check out https://immuneering.com.

Immuneering Corp Investment Alerts

Immuneering Corp Upcoming and Recent Events

Immuneering Largest EPS Surprises

View All Earnings Estimates

Immuneering Corp Environmental, Social, and Governance (ESG) Scores

Immuneering Stock Institutional Investors

Note, although Immuneering Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immuneering Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 148.62 M.

Immuneering Profitablity

Management Efficiency

Immuneering Corp has return on total asset (ROA) of (0.579) % which means that it has lost $0.579 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0248) %, meaning that it created substantial loss on money invested by shareholders. Immuneering Corp's management efficiency ratios could be used to measure how well Immuneering Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -1.27 in 2025. Return On Capital Employed is likely to rise to -1.35 in 2025. At this time, Immuneering Corp's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.4 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 65.1 M in 2025.

Technical Drivers

As of the 19th of July, Immuneering Corp retains the Downside Deviation of 7.54, market risk adjusted performance of 2.3, and Risk Adjusted Performance of 0.2174. Immuneering Corp technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Immuneering Corp Price Movement Analysis

Immuneering Corp Insider Trading Activities

Immuneering Corp Outstanding Bonds

Immuneering Corp Predictive Daily Indicators

Immuneering Corp Forecast Models

Immuneering Corp's time-series forecasting models are one of many Immuneering Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immuneering Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Immuneering Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Immuneering shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Immuneering Corp. By using and applying Immuneering Stock analysis, traders can create a robust methodology for identifying Immuneering entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Immuneering analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Immuneering analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Immuneering Corp stock analysis indicators help investors evaluate how Immuneering Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Immuneering Corp shares will generate the highest return on investment. By understating and applying Immuneering Corp stock analysis, traders can identify Immuneering Corp position entry and exit signals to maximize returns.

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.